Guardian Pharmacy Services, Inc.
GRDN
NYSE·Healthcare·Medical - Care Facilities·Mkt cap $2.6B
$40.77
▲ +1.59%
P/E
39.20
Mkt Cap
$2.6B
52-Wk Range
$23.14–$47.02
52-Week Range
$23.14 - $47.02
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 41.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Specialized focus on lower-acuity long-term care facilities with tailored solutions
- Proprietary data warehouse and Guardian Compass analytics platform for operational optimization
- Integrated clinical expertise combined with technology for medication management and compliance
- Established network of local pharmacies enabling personalized service and rapid response
- Deep regulatory knowledge and compliance infrastructure specific to LTCF requirements
Bear Case
2 risks
- Low volatility (beta 0.1).
- Significant premium - growth priced in
Growth
Stable outlook
Aging U.S. population increasing demand for long-term care facility services
Value
Significant premium - growth priced in
Momentum
Stable
+0.7% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying GRDN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 6, 2026
Reported EPS of $0.29 vs $0.26 consensus (+10.8% surprise). Revenue of $351.8M vs $340.4M expected (+3.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+10.8%
Revenue trend · last 8Q
—
+20%
+20%
+15%
+20%
+17%
+2%
+2%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$314.4M
$338.6M
$329.3M
$344.3M
$377.4M
$397.6M
$336.6M
$351.8M
Margins · last 8Q
Gross
22.8%
Operating
5.9%
Profit
6.2%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Oppenheimer · Aug 7, 2026
vs Industry
How GRDN stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related